IL-6 and MYC collaborate in plasma cell tumor formation in mice

od Rutsch, Sebastian, Neppalli, Vishala T., Shin, Dong-Mi, DuBois, Wendy, Morse, Herbert C., Goldschmidt, Hartmut, Janz, Siegfried
Izdano 2010

Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility

od Zhang, Ke, Kagan, Daniel, DuBois, Wendy, Robinson, Richard, Bliskovsky, Valery, Vass, William C., Zhang, Shuling, Mock, Beverly A.
Izdano 2009

3’Igh enhancers hs3b/hs4 are dispensable for Myc deregulation in mouse plasmacytomas with T(12;15) translocations

od Kovalchuk, Alexander L., Sakai, Tomomi, Qi, Chen-Feng, Du Bois, Wendy, Dunnick, Wesley A., Cogné, Michel, Morse, Herbert C.
Izdano u Oncotarget (2018)

Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene

od Bliskovsky, Valery, Ramsay, Edward S., Scott, John, DuBois, Wendy, Shi, Wei, Zhang, Shuling, Qian, Xiaolan, Lowy, Douglas R., Mock, Beverly A.
Izdano 2003

The transcription factor MZF1 differentially regulates murine Mtor promoter variants linked to tumor susceptibility

od Zhang, Shuling, Shi, Wei, Ramsay, Edward S., Bliskovsky, Valery, Eiden, Adrian Max, Connors, Daniel, Steinsaltz, Matthew, DuBois, Wendy, Mock, Beverly A.
Izdano u J Biol Chem (2019)

CDDO-Imidazolide inhibits growth and survival of c-Myc-induced mouse B cell and plasma cell neoplasms

od Han, Seong-Su, Peng, Liangping, Chung, Seung-Tae, DuBois, Wendy, Maeng, Sung-Ho, Shaffer, Arthur L, Sporn, Michael B, Janz, Siegfried
Izdano 2006

Mouse tumor susceptibility genes identify drug combinations for multiple myeloma

od Zhang, Shuling, DuBois, Wendy, Zhang, Ke, Simmons, John K., Hughitt, V. Keith, Gorjifard, Sayeh, Gaikwad, Snehal, Peat, Tyler J., Mock, Beverly A.
Izdano u J Cancer Metastasis Treat (2020)

Efficiency Alleles of the Pctr1 Modifier Locus for Plasmacytoma Susceptibility

od Zhang, Shuling-L., DuBois, Wendy, Ramsay, Edward S., Bliskovski, Valeri, Morse, Herbert C., Taddesse-Heath, Leki, Vass, William C., DePinho, Ronald A., Mock, Beverly A.
Izdano 2001

Global gene expression profiling in mouse plasma cell tumor precursor and bystander cells reveals potential intervention targets for plasma cell neoplasia

od LeGrand, Jason, Park, Eun Sung, Wang, Hongyang, Gupta, Shalu, Owens, James D., Nelson, Patrick J., DuBois, Wendy, Bair, Thomas, Janz, Siegfried, Mushinski, J. Frederic
Izdano 2012

CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer

od Malik, Navdeep, Yan, Hualong, Yang, Howard H., Ayaz, Gamze, DuBois, Wendy, Tseng, Yu-Chou, Kim, Young-Im, Jiang, Shunlin, Liu, Chengyu, Lee, Maxwell, Huang, Jing
Izdano u PLoS Genet (2021)

Susceptibility to Anthrax Lethal Toxin Is Controlled by Three Linked Quantitative Trait Loci

od McAllister, Ryan D., Singh, Yogendra, du Bois, Wendy D., Potter, Michael, Boehm, Thomas, Meeker, Nathan D., Fillmore, Parley D., Anderson, Lisa M., Poynter, Matthew E., Teuscher, Cory
Izdano 2003

mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells

od Smrž, Daniel, Kim, Mi-Sun, Zhang, Shuling, Mock, Beverly A., Smržová, Šárka, DuBois, Wendy, Simakova, Olga, Maric, Irina, Wilson, Todd M., Metcalfe, Dean D., Gilfillan, Alasdair M.
Izdano 2011

AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements

od Kovalchuk, Alexander L., duBois, Wendy, Mushinski, Elizabeth, McNeil, Nicole E., Hirt, Carsten, Qi, Chen-Feng, Li, Zhaoyang, Janz, Siegfried, Honjo, Tasuku, Muramatsu, Masamichi, Ried, Thomas, Behrens, Timothy, Potter, Michael
Izdano 2007

Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production

od Zhang, Shuling, Readinger, Julie A., DuBois, Wendy, Janka-Junttila, Mirkka, Robinson, Richard, Pruitt, Margaret, Bliskovsky, Val, Wu, Julie Z., Sakakibara, Kaori, Patel, Jyoti, Parent, Carole A., Tessarollo, Lino, Schwartzberg, Pamela L., Mock, Beverly A.
Izdano 2011

ATP-degrading ENPP1 is required for survival (or persistence) of long-lived plasma cells

od Wang, Hongsheng, Gonzalez-Garcia, Ines, Traba, Javier, Jain, Shweta, Conteh, Solomon, Shin, Dong-Mi, Qi, Chenfeng, Gao, Yuanyuan, Sun, Jiafang, Kang, Sungyun, Abbasi, Sadia, Naghashfar, Zohreh, Yoon, Jeongheon, DuBois, Wendy, Kovalchuk, Alexander L., Sack, Michael N., Duffy, Patrick, Morse, Herbert C.
Izdano u Sci Rep (2017)

Increased mammalian lifespan and a segmental and tissue-specific slowing of aging following genetic reduction of mTOR expression

od Wu, J. Julie, Liu, Jie, Chen, Edmund B., Wang, Jennifer J., Cao, Liu, Narayan, Nisha, Fergusson, Marie M., Rovira, Ilsa I., Allen, Michele, Springer, Danielle A., Lago, Cory U., Zhang, Shuling, DuBois, Wendy, Ward, Theresa, deCabo, Rafael, Gavrilova, Oksana, Mock, Beverly, Finkel, Toren
Izdano 2013

Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation

od Simmons, John K., Michalowski, Aleksandra M., Gamache, Benjamin J., DuBois, Wendy, Patel, Jyoti, Zhang, Ke, Gary, Joy, Zhang, Shuling, Gaikwad, Snehal, Connors, Daniel, Watson, Nicholas, Leon, Elena, Chen, Jin-Qiu, Kuehl, W. Michael, Lee, Maxwell P., Zingone, Adriana, Landgren, Ola, Ordentlich, Peter, Huang, Jing, Mock, Beverly A.
Izdano u Mol Cancer Ther (2017)

mTOR intersects antibody-inducing signals from TACI in marginal zone B cells

od Sintes, Jordi, Gentile, Maurizio, Zhang, Shuling, Garcia-Carmona, Yolanda, Magri, Giuliana, Cassis, Linda, Segura-Garzón, Daniel, Ciociola, Alessandra, Grasset, Emilie K., Bascones, Sabrina, Comerma, Laura, Pybus, Marc, Lligé, David, Puga, Irene, Gutzeit, Cindy, He, Bing, DuBois, Wendy, Crespo, Marta, Pascual, Julio, Mensa, Anna, Aróstegui, Juan Ignacio, Juan, Manel, Yagüe, Jordi, Serrano, Sergi, Lloreta, Josep, Meffre, Eric, Hahne, Michael, Cunningham-Rundles, Charlotte, Mock, Beverly A., Cerutti, Andrea
Izdano u Nat Commun (2017)